《新股消息》奈雪的茶(02150.HK)孖展額逾1,055億元公開超購206倍 和黃醫藥(00013.HK)足額
綜合券商數據,奈雪的茶(02150.HK)截至下午約6時累計錄得孖展認購額超過1,055億元,當中耀才借出近182億元,輝立孖展額亦回升至137億元,以公開發售部分集資5.09億元計超額認購逾206倍。
早前有市場消息指,奈雪的茶定價指引爲每股19.8元,屬招股價範圍的上限。
另外,和黃醫藥(00013.HK)(HCM.US)累計錄得孖展額近6.43億元,以公開集資5.85億元計錄得足額。
奈雪的茶及和黃醫藥的招股期同於明日(23日)中午結束,料於30日上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.